Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDR | P35968 | 3/20 | 0.82 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.82 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.82 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.82 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.82 |
| ▸ | LMNA | P02545 | 4/20 | 0.65 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.65 |
| ▸ | HIF1A | Q16665 | 4/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.65 |
| ▸ | ABL1 | P00519 | 2/20 | 0.65 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.65 |
| ▸ | HTT | P42858 | 2/20 | 0.65 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.65 |
| ▸ | USP2 | O75604 | 1/20 | 0.65 |
| ▸ | TUBB4A | P04350 | 4/20 | 0.54 |
| ▸ | TUBB | P07437 | 4/20 | 0.54 |
| ▸ | TUBA3C | P0DPH7 | 4/20 | 0.54 |
| ▸ | TUBA1B | P68363 | 4/20 | 0.54 |
| ▸ | TUBA4A | P68366 | 4/20 | 0.54 |
| ▸ | TUBB4B | P68371 | 4/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Flubendazole SCHEMBL29409278 | 1.00 | KDR (0.82) | KDRMAPK1ADORA3PTGS1RXFP1 | |
| Flubendazole SCHEMBL22321861 | 0.99 | KDR (0.80) | KDRMAPK1ADORA3PTGS1RXFP1 | |
| Flubendazole SCHEMBL8005889 | 0.95 | KDR (0.76) | KDRMAPK1ADORA3PTGS1RXFP1 | |
| Flubendazole SCHEMBL28005737 | 0.95 | KDR (0.76) | KDRMAPK1ADORA3PTGS1RXFP1 | |
| Flubendazole SCHEMBL453978 | 0.94 | KDR (0.78) | KDRMAPK1ADORA3PTGS1RXFP1 | |
| Flubendazole SCHEMBL20815724 | 0.91 | KDR (0.69) | KDRMAPK1ADORA3PTGS1RXFP1 | |
| Flubendazole SCHEMBL31704404 | 0.90 | KDR (1.00) | KDRMAPK1ADORA3PTGS1RXFP1 | |
| Flubendazole SCHEMBL6232065 | 0.90 | KDR (1.00) | KDRMAPK1ADORA3PTGS1RXFP1 | |
| Mebendazole SCHEMBL15860 | 0.89 | ABL1 (0.82) | KDRMAPK1ADORA3PTGS1RXFP1 | |
| Mebendazole SCHEMBL3429179 | 0.89 | ABL1 (0.82) | KDRMAPK1ADORA3PTGS1RXFP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4924 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12582717-B2 | Protein based excipient for active pharmaceutical ingredients | DISPERSOME IP APS (NL) | 2026-03-24 | — | — | US | claimed |
| WO-2026044269-A1 | COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING ALZHEIMER'S DISEASE AND OTHER | SAFWAT SHERIF (US) | 2026-02-26 | — | — | WO | claimed |
| US-20250352518-A1 | A BENZIMIDAZOLE COMPOUND WITH ANTIHELMINTHIC ACTIVITY FOR USE IN REVERSING, ARRESTING OR SLOWING DOWN CELLULAR AGEING IN A VERTEBRATE SUBJECT | RAVAN BIO LIMITED (GB) | 2025-11-20 | — | — | US | claimed |
| US-12465623-B2 | Use of parasites and extracellular vesicles obtained from parasites in cancer treatment | YEDITEPE UNIVERSITESI (TR) | 2025-11-11 | — | — | US | claimed |
| EP-4633643-A1 | USE OF BORON FOR THE TREATMENT OF LEISHMANIASIS DISEASE OF NEURONAL ORIGIN | Yeditepe Universitesi (TR) | 2025-10-22 | — | — | EP | claimed |
| EP-4633617-A1 | USE OF BORON FOR THE TREATMENT OF LEISHMANIASIS DISEASE | Yeditepe Universitesi (TR) | 2025-10-22 | — | — | EP | claimed |
| WO-2025215232-A1 | A COMPOSITION COMPRISING A SAPONIN AND/OR AN ANTHELMINTIC AND/OR A MITOCHONDRIAL UNCOUPLER FOR THE TREATMENT OF LIVER DISEASE | RAINCASTLE BIO. LIMITED (GB) | 2025-10-16 | — | — | WO | claimed |
| EP-4389116-B1 | PHARMACEUTICAL AQUEOUS FLUBENDAZOLE SUSPENSION | DECHRA LTD (GB) | 2025-09-10 | — | — | EP | claimed |
| US-20250276967-A1 | HETEROCYCLIC COMPOUNDS AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES | SIGNAL PHARMACEUTICALS, LLC | 2025-09-04 | — | — | US | claimed |
| EP-3965808-B1 | USE OF PARASITES AND EXTRACELLULAR VESICLES OBTAINED FROM PARASITES IN CANCER TREATMENT | UNIV YEDITEPE (TR) | 2025-09-03 | — | — | EP | claimed |
| EP-0427582-A2 | Non-aqueous micellar solutions of various drugs | Crooks, Michael John (AU) | 1991-05-15 | — | — | EP | claimed |
| US-4983586-A | Decreasing precipitation at injection site or in lungs or other organs by combining with hydroxypropyl-beta-cyclodextrin | UNIVERSITY OF FLORIDA (US) | 1991-01-08 | — | — | US | claimed |
| WO-1990014125-A1 | DISPENSING DEVICES | COOPERS ANIMAL HEALTH LIMITED (GB) | 1990-11-29 | — | — | WO | claimed |
| EP-0398663-A1 | Dispensing devices | COOPERS ANIMAL HEALTH LIMITED (GB) | 1990-11-22 | — | — | EP | claimed |
| EP-0335545-A2 | Pharmaceutical formulations for parenteral use | UNIVERSITY OF FLORIDA (US) | 1989-10-04 | — | — | EP | claimed |
| EP-0090368-B1 | ANTHELMINTIC PREPARATIONS | HOECHST UK LIMITED (GB) | 1987-09-02 | — | — | EP | claimed |
| EP-0224249-A1 | Amorphous benzimidazole derivatives | SYNTEX (U.S.A.) INC. (US) | 1987-06-03 | — | — | EP | claimed |
| EP-0202568-A1 | Anthelmintic compositions | SYNTEX (U.S.A.) INC. (US) | 1986-11-26 | — | — | EP | claimed |
| EP-0146573-A1 | PHARMACEUTICAL COMPOSITIONS WITH ANTHELMINTIC ACTIVITY, DOSAGE UNITS THEREOF AND METHOD FOR TREATING HELMINTHIASIS IN ANIMALS | HOECHST AKTIENGESELLSCHAFT (DE) | 1985-07-03 | — | — | EP | claimed |
| WO-1984004677-A1 | PHARMACEUTICAL COMPOSITIONS WITH ANTHELMINTIC ACTIVITY, DOSAGE UNITS THEREOF AND METHOD FOR TREATING HELMINTHIASIS IN ANIMALS | HOECHST AG (DE) | 1984-12-06 | — | — | WO | claimed |